Select Location
We need your delivery location to continue browsing
Prescription Required
30 Tablet in Bottle
Erlotinib
Keep in cold place
Delivering To: —
Overview
Erlonat 100mg tablet is an anticancer drug prescribed to patients suffering from advanced non-small cell lung cancer and pancreatic cancer. This tablet has a salt constituent called 'Erlotinib,' which belongs to the drug class of 'kinase inhibitors. It stops the working of the abnormal protein that leads to cancerous growth. Erlonat is not recommended for children below 18 years of age. If you are taking any antacid medications, maintain a gap of 2-3 hours after taking Erlonat 100mg Tablet.
Lung Cancer, Metastatic Cancer
Side effects are unwanted symptoms that can occur from any medical treatment. Like other medications, the Erlonat 100mg Tablet can also have adverse effects on the body, most of which resolve without the need for medical attention.
Some common side effects include:
Fever
Rash
Cough
Fatigue
Diarrhea
Hair loss
Vomiting
Bone pain
Constipation
Muscles pain
Appetite loss
Abdominal pain
Difficulty in breathing
Infection in the mouth and stomach
Contact your doctor immediately if you experience any severe or unusual side effects.
Erlonat 100mg tablet is a prescription-based anticancer drug that should be administered orally. The doctor determines the dosage of this tablet based on your health condition. It should be taken on an empty stomach, and it must not be chewed or crushed.
Erlonat 100mg tablet contains its salt constituents known as Erlotinib, which belongs to the drug class of kinase inhibitors. Epidermal growth factor receptors (EGFR) are proteins that are found on lung cancer cells. These proteins receive signals and regulate the growth of cancer cells. This drug binds to the chemical messenger and disturbs the cancer signaling pathway mediated by EGFR. This is how it blocks the growth and multiplication of the cancer cells.

Alcohol
consult your doctor
The interaction of alcohol with this drug is still unknown. It is advisable not to consume alcohol while taking the Erlonat 100mg tablet. It is advised to consult your doctor for further information.

Pregnancy
consult your doctor
Erlonat tablet may be considered unsafe during pregnancy. Please consult your doctor in such a condition.

Breast Feeding
consult your doctor
Erlonat 100mg tablet is probably not safe if you're breastfeeding. Kindly consult your doctor.

Driving
unsafe
It is advisable not to drive or operate heavy machinery after taking an Erlonat 100mg tablet, as you may feel dizzy.

Kidney
safe if prescribed
Erlonat 100mg tablet is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.

Liver
safe if prescribed
Inform your doctor before starting the Erlonat 100mg tablet if you have liver disease to avoid any serious side effects.
It is advised not to miss any scheduled dosage of Erlonat 100mg tablet. In case you miss a dose, consult your doctor immediately.
Don't overdose to compensate for the missed one. Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Inform your doctor immediately if you see blood in your stools after taking Erlonat 100mg Tablet.
Taking Erlonat 100mg Tablet can make your skin sensitive. So wear high SPF sunscreen while going out or exposed to direct sun rays.
Erlonat Tablet is not considered to be safe for pregnant and breastfeeding women, as it may pass through the mother and harm the baby.
It is advised to use trusted methods of birth control and contraceptive pills to delay pregnancy while under treatment with Erlonat 100mg Tablet.
Diarrhea is the most common side effect after taking Erlonat 100mg Tablet. So, drink plenty of water and fluid to keep your body hydrated.
Do not take antacids medicine (Medicine lowers the stomach acid) with Erlonat 100mg Tablet, as it may interact with the tablet and can affect the action.
Erlonat 100mg Tablet is considered to be safe for diabetic patients. However, it is important to consult your doctor about doses before taking them.
After taking the last medication, the doctor recommends waiting at least one month before getting pregnant. Therefore, while taking the Erlonat 100mg tablet for treatment, avoid getting pregnant by using safe birth control techniques and contraceptive pills.
It is recommended that you continue taking the Erlonat 100mg tablet until your doctor instructs you to do so, even if rashes are observed as a frequent side effect. Avoid direct sunlight and apply sunscreen with a high SPF.
Erlonat 100mg Tablet should be taken with or without food as your healthcare expert prescribes. It is advised to take this pill with water at once; do not chew, break, or crush it.
Erlonat 100mg Tablet belongs to the drug class of kinase inhibitors that inhibit the abnormal protein that signals the multiplication and growth of cancer cells. It is not a chemotherapy medicine.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
1. Bareschino, M. A., Schettino, C., Troiani, T., Martinelli, E., Morgillo, F., & Ciardiello, F. (2007). Erlotinib in cancer treatment. Annals of oncology, 18, vi35-vi41.
2. Abdelgalil, A. A., Al-Kahtani, H. M., & Al-Jenoobi, F. I. (2020). Erlotinib. In Profiles of drug substances, excipients and related methodology (Vol. 45, pp. 93-117). Academic Press.
3. Tsao, M. S., Sakurada, A., Cutz, J. C., Zhu, C. Q., Kamel-Reid, S., Squire, J., ... & Shepherd, F. A. (2005). Erlotinib in lung cancer—molecular and clinical predictors of outcome. New England Journal of Medicine, 353(2), 133-144.
4. Steins, M., Thomas, M., & Geißler, M. (2018). Erlotinib. Small molecules in oncology, 1-17.
5. Cohen, M. H., Johnson, J. R., Chen, Y. F., Sridhara, R., & Pazdur, R. (2005). FDA drug approval summary: erlotinib (Tarceva®) tablets. The oncologist, 10(7), 461-466.
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.